Al Rifai M, Silverman MG, Nasir K, Budoff MJ, Blankstein R, Szklo M, et al
"For retatrutide, the findings from TRIUMPH-4 are encouraging, and with seven additional phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis," a Lilly spokesperson said in a statement to Fox News Digital
Position the vial upright and away from the refrigerator door where temperature fluctuations occur
The risk of weight gain and hypoglycemia can also be reduced with this combination therapy
This article examines the reality behind GLP-1 patch claims, ongoing research, and how to identify fraudulent products
It isn't known whether the medications cause this in humans